Topical tacrolimus - A novel treatment alternative for cutaneous chronic graft-versus-host disease

Transplant International

Volumn 16, Issue 9, 2003, Pages 665-670

  Elad, Sharon ^a   Or, Reuven ^a   Resnick, Igor ^a   Shapira, Michael Y ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

GVHD; Skin; Tacrolimus; Topical

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; FLUDARABINE; METHOTREXATE; PREDNISONE; TACROLIMUS; THALIDOMIDE;

ADULT; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; CUTANEOUS CHRONIC GRAFT VERSUS HOST DISEASE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOMODULATION; LEUKEMIA; LYMPHOMA; MALE; MYELODYSPLASTIC SYNDROME; OINTMENT; PHOTOTHERAPY; PRIORITY JOURNAL; PROPHYLAXIS; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; SKIN MANIFESTATION; TREATMENT OUTCOME; ULTRAVIOLET B RADIATION;

ADMINISTRATION, TOPICAL; ADULT; CHRONIC DISEASE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; OINTMENTS; PILOT PROJECTS; RETREATMENT; SKIN DISEASES; STEROIDS; TACROLIMUS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0141816780     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00147-003-0594-2     Document Type: Article

References (34)

1. Sullivan KM (1999) Graft-versus-host disease. In: Thomas ED, Blume KG, Forman SJ (eds) Hematopoietic cell transplantation, 2nd edn. Blackwell Science, Malden, p 515
2. Wingard J, Paintadosi S, Vogelsang G, et al. (1989) Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood 74:1428
3. Arai S, Vogelsang GB (2000) Management of graft-versus-host disease. Blood Rev 14:190
4. Aractingi S, Chosidow O (1998) Cutaneous graft-versus-host disease. Arch Dermatol 134:602
5. Child FJ, Ratnavel R, Watkins P, et al. (1999) Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD). Bone Marrow Transplant 23:881
6. Volc-Platzer B, Honigsmann H, Hinterbeger W, Wolff K (1990) Photochemotherapy improves chronic cutaneous graft-versus-host disease. J Am Acad Dermatol 23:220
7. Enk CD, Elad S, Vexler A, Kapelushnik J, Gorodetsky R, Kirschbaum M (1998) Chronic graft-versus-host disease treated with UVB phototherapy. Bone Marrow Transplant 22:1179
8. Reitamo S, Rissanen J, Remitz A, et al. (1998) Tacrolimus ointment does not affect collagen synthesis: results of a single-center randomized trial. J Invest Dermatol 111:396
9. Alaiti S, Kang S, Fiedler VC, et al. (1998) Tacrolimus (FK506) ointment for atopic dermatitis: a phase I study in adults and children. J Am Acad Dermatol 38:69
10. Reitamo S, Wollenberg A, Schopf E, et al. (2000) Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. Arch Dermatol 136:999
11. Ruzicka T, Bieber T, Schopf E, et al. (1997) A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 337:816
12. Boguniewicz M, Fiedler VC, Reimer S, Lawrence ID, Leung DY, Hanifin JM (1998) A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. J Allergy Clin Immunol 102:637
13. Nakagawa H, Etoh T, Ishibashi Y, et al. (1994) Tacrolimus ointment for atopic dermatitis. Lancet 344:883
14. Goto T, Kino T, Hatanaka H, et al. (1987) Discovery of FK-506, a novel immunosuppressant isolated from Streptomyces tsukubaensis. Transplant Proc 19 [Suppl 6]:4
15. Tocci MJ, Matkovich DA, Collier KA, et al. (1989) The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol 143:718
16. Letko E, Bhol K, Pinar V, Foster CS, Ahmed AR (1999) Tacrolimus (FK 506). Ann Allergy Asthma Immunol 83:179
17. Skaehill PA (2001) Tacrolimus in dermatologic disorders. Ann Pharmacother 35:582
18. Hauk PJ, Hamid QA, Chrousos GP, Leung DY (2000) Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol 105:782
19. Hauk PJ, Leung DY (2001) Tacrolimus (FK506): new treatment approach in superantigen-associated diseases like atopic dermatitis? J Allergy Clin Immunol 107:391
20. Reitamo S (2001) Tacrolimus: a new topical immunomodulatory therapy for atopic dermatitis. J Allergy Clin Immunol 107:445
21. Van Hooff JP, Christiaans MH (1999) Use of tacrolimus in renal transplantation. Transplant Proc 31:3298
22. Van Mourik ID, Kelly DA (2001) Immunosuppressive drugs in paediatric liver transplantation. Paediatr Drugs 3:43
23. De Bonis M, Reynolds L, Barros J, Madden BP (2001) Tacrolimus as a rescue immunosuppressant after heart transplantation. Eur J Cardiothorac Surg 19:690
24. Taylor DO, Barr ML, Meiser BM, Pham SM, Mentzer RM, Gass AL (2001) Suggested guidelines for the use of tacrolimus in cardiac transplant recipients. J Heart Lung Transplant 20:734
25. Hanauer SB, Dassopoulos T (2001) Evolving treatment strategies for inflammatory bowel disease. Annu Rev Med 52:299
26. Neuhaus P, McMaster P, Calne R, et al. (1994) Neurological complications in the European multicentre study of FK506 and cyclosporine in primary liver transplantation. Transpl Int 7 [Suppl 1]:S27
27. Pirsch JD, Miller J, Deierhoi MH, Vincenti F, Filo RS (1997) A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation 63:977
28. Fung JJ, Alessiani M, Abu-Elmagd K, et al. (1991) Adverse effects associated with the use of FK506. Transplant Proc 23:3105
29. Paul LC (2001) Overview of side effects of immunosuppressive therapy. Transplant Proc 33:2089
30. Otley CC, Pittelkow MR (2000) Skin cancer in liver transplant recipients. Liver Transpl 6:253
31. O'Byrne KJ, Dalgleish AG (2001) Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 85:473
32. Antin JH, Ferrara JLM (1992) Cytokine dysregulation and acute graft-versus-host disease. Blood 80:2964
33. Washington K, Bentley RC, Green A, Olson J, Treem WR, Krigman HR (1997) Gastric graft-versus-host disease: a blinded histologic study. Am J Surg Pathol 21:1037
34. Choi CJ, Nghiem P (2001) Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients. Arch Dermatol 137:1202